FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 13681537 · Received March 7, 2022

Report

Report Number
3004464228-2022-03814
Event Type
Malfunction
Date Received
March 7, 2022
Date of Event
December 5, 2021
Report Date
December 5, 2021
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120033
PMA / PMN Number
K192659
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

NO ALARMS, TIMEOUTS, NOR DRIVE STALLS WERE OBSERVED IN THE DATA. THE SOFT CANNULA WAS OBSERVED TO BE DAMAGED. IT COULD NOT BE DETERMINED WHEN THIS DAMAGE OCCURRED, NOR IF THIS DAMAGE RESULTED IN A FAILURE TO DELIVER INSULIN. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Description of Event or Problem · 0

IT WAS REPORTED THE PATIENTS BLOOD GLUCOSE LEVEL ROSE TO OVER 500 MG/DL WHILE WEARING THE POD BETWEEN 4 AND 24 HOURS ON THE ABDOMEN. AS TREATMENT, A MEW POD WAS PLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1963564 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 L46125 20385081120033

Patients

Seq Age Sex Outcome Treatment
1 15 YR Male